LRRK2 and Parkinson disease: In contrast, another study reported a low frequency of the most common mutations in a well-powered (99.9%) PD sample, with LRRK2 p.(Gly2019Ser) present in only 0.11% of cases and SNCA duplications in 0.045% [17].